Decreased incidence of graft-versus-host disease and improved survival with methotrexate combined with cyclosporin compared with monotherapy in recipients of bone marrow from donors other than HLA identical siblings.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples